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A Novel 22q11.2 Microdeletion in DiGeorge
Syndrome
To the Editor:
DiGeorge syndrome (DGS; MIM 188400) is a multiple-
malformation syndrome characterized by aplasia or hy-
poplasia of the thymus; immunodeficiency, aplasia, or
hypoplasia of the parathyroid glands; conotruncal car-
diac defects; and typical facial anomalies(DiGeorge
1965; Conley et al. 1979). Despite causal heterogeneity
(Lammer and Opitz 1986), ∼90% of patients with DGS
have hemizygosity of an ∼1.5–3-Mb region within
22q11.2 (Driscoll et al. 1990; Scambler et al. 1991; Dris-
coll et al. 1992a). Because of phenotypic overlap, the
same deletion was demonstrated in the majority of pa-
tients with velo-cardio-facial syndrome (VCFS; MIM
192430) (Driscoll et al. 1992b; Carlson et al. 1997b),
which was initially characterized by hypernasal speech
caused by cleft palate, cardiac anomalies, learning dis-
abilities, and typical facial appearance (Shprintzen et al.
1978, 1981). In addition, 22q11.2 deletions were ob-
served in cases fitting within the spectrum of Cayler syn-
drome (MIM 125520) (Giannotti et al. 1994), Takao
conotruncal anomaly face syndrome (contained in MIM
188400) (Burn et al. 1993), Noonan syndrome (MIM
163915) (Wilson et al. 1993), Kousseff syndrome (MIM
245210) (Nickel et al. 1994), andOpitz GBBB syndrome
(MIM 145410) (McDonald-McGinn et al. 1995).Mean-
while, it became evident that deletion 22q11.2 is asso-
ciated with a phenotypic spectrum that may present as
one of the aforementioned syndromes or any condition
in between them that has considerable inter- and intra-
familial variability (De Silva et al. 1995; Leana-Cox et
al. 1996; Devriendt et al. 1997; Ryan et al. 1997). There-
fore, 22q11.2 microdeletion is one of the most common
genetic defects, with an estimated incidence of 11 in
5,000 (Wilson et al. 1994; Tezenas Du Montcel et al.
1996). According to Carlson et al. (1997b), 90% of
patients with deletions have a common 3-Mb deletion,
8.5% have a proximal 1.5-Mb deletion, and 3% have
unique nested proximal deletions, which may define a
proximal shortest region of overlap within the com-
monly deleted 3-Mb region. Because of two patientswith
small deletions in the distal part of the 3-Mb deletion,
a distal shortest region of overlap within the deleted
region may also be defined (Kurahashi et al. 1997;
O’Donnell et al. 1997). However, there is no obvious
correlation between the site or size of the deletion and
the severity of the clinical manifestations, and position
effects have been taken into consideration (Carlson et
al. 1997b; Kurahashi et al. 1997; O’Donnell et al. 1997).
We describe here a novel 22q11.2 microdeletion in a
family with mild to severe phenotype. This deletion is
adjacent to but does not overlap with the known dele-
tions. Nevertheless, it shows similar clinical character-
istics and may therefore give a clue to the mechanisms
and genes involved in phenotype determination in
22q11.2 deletions.
Patient III:3 was primarily investigated in the context
of a study of incidence and significance of 22q11.2 hemi-
zygosity in patients with interrupted aortic arch (Rauch
et al. 1998b). Within that study, she was the only patient
with symptoms of the DGS/VCFS spectrum who did not
have the 22q11.2 deletion and, therefore, prompted fur-
ther analysis. Phenotype assessment of the patient, her
parents, and her sibs was performed before molecular
studies and included dysmorphologic analysis of lym-
phocyte subpopulations by flow cytometry on an Or-
thoscan, by means of fluorochrome-labeled antibodies
against CD3, CD4, CD8, and CD19; and surface im-
munoglobulin (according to Becton-Dickinson). Diph-
theria toxoid and tetanus toxoid were measured after
vaccination, by means of a commercially available en-
zyme-linked immunosorbent assay (ELISA) (ABICAP;
Abion). Parathyroid hormone levels were determined by
chemoluminescence-ELISA (Nichols) of the patient’s
sera. Cardiac status was established by echocardio-
graphy and angiography in the patient and by echocardi-
ography only in the patient’s parents and sibs. Flexible
transnasal pharyngoscopy was performed in the pa-
tient’s sister and mother, to exclude velopharyngeal
insufficiency.
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In the patient, conventional karyotyping of GTG-
banded chromosomes from peripheral T lymphocytes
and fibroblasts was performed at an ∼550-band level,
according to Mitelman 1995, pp 14–21). The patient,
both of her sibs, and her mother were investigated
by FISH with the DNA probes D22S75 (ONCOR),
cHKAD26 (Kurahashi et al. 1994, 1997) (kindly pro-
vided by the Japanese Cancer Research Resources Bank)
and bacterial artificial chromosome (BAC) 438P22 (see
below) on metaphase chromosomes from peripheral T
lymphocytes. In the patient, FISH was performed with
the additional probes Tuple1 (VYSIS), M-bcr/abl, m-bcr/
abl (ONCOR), and BAC 458J22. The DNA probes
D22S75 and cHKAD26 were also analyzed in meta-
phases from fibroblasts of the patient. The commercially
produced probes were used according to the manufac-
turer’s instructions, or two-color FISH was performed
with the critical probe biotin-labeled and with a digox-
igenin-labeled centromeric 14/22 probe (ONCOR), as
described elsewhere (Rauch et al. 1996). The Research
Genetics human BAC DNA pools, release IV, were
screened with the polymorphic marker D22S425 (see
below), according to manufacturer’s instructions. Posi-
tive BACs were tested and amplified according to Re-
search Genetics guidelines. Two–color fiber-FISH was
performed with BAC 438P22 and 458J22, on fixed cul-
tured T lymphocytes from a healthy control, as described
elsewhere (Fidlerova et al. 1994).
The patient and her parents had been tested before,
for the following 10 short–tandem-repeat polymorphism
(STRP) markers from the 22q11.2 region: D22S264
(Marineau et al. 1992); D22S311 and D22S306 (Porter
et al. 1993); D22S427 (Gyapay et al. 1994); D22S941
and D22S944 (Morrow et al. 1995); and D22S1638,
D22S1648, D22S1623, and D22S308 (Carlson et al.
1997a, Genome Database), as described elsewhere
(Rauch et al. 1998b). Subsequently, the patient, her sibs,
her parents, and her maternal grandparents were tested
for STRPs at the loci D22S311 (Genome Database
190609), D22S1709 (Genome Database 5865052),
D22S306 (Genome Database 190620), D22S308 (Ge-
nome Database 190623), D22S425 (Genome Database
199610), D22S303 (Genome Database 190616),
D22S257 (Genome Database 180549), D22S301 (Ge-
nome Database 190613), D22S156 (Genome Database
177327), TOP1P2 (Genome Database 159908),
D22S1144 (Genome Database 606049; SangerCentre
bK929C8), and D22S1167 (Genome Database 610902;
Sanger Centre bK373H7), by PCR amplification ofDNA
extracted from fresh peripheral blood and separation on
6% denaturing polyacrylamide gels (41 cm) in a Li-cor
(MWG-Biotech) sequencer, as described elsewhere
(Rauch et al. 1998b). Additional mapping information
about the STRP markers was obtained by both a search
of the BLAST database by means of the PCR primer
sequences and data produced by the Chromosome 22
Mapping Group at the Sanger Centre, which were ob-
tained from the World Wide Web.
In addition to interrupted aortic arch type B, patient
III:3 had truncus arteriosus communis type A4, T-cell
deficiency, Pseudomonas aeruginosa sepsis, hypoplasia
of halluces and toenails, choanal stenosis, retrognathia,
and ear anomalies (fig. 1a–d). After repair of her con-
genital heart defect, the patient died neonatally, from
heart failure and sepsis. Dysmorphologic analysis re-
vealed subtle anomalies in her sister andmother,whereas
her brother and father appeared normal. Minor anom-
alies in the mother included external strabismus, retrog-
nathia, posteriorly angulated ears, broad neck with low
posterior hairline, short 5th fingers (Dubois sign), and
a high-arched palate with a minimal nick in the uvula
(fig. 1e and f). Her occipitofrontal circumference (OFC)
was 52 cm (!3d centile), and her height was 159 cm
(10th centile). She had recurrent bronchitis and otitis
media, but immunologic investigations revealed normal
results. Despite some learning problems, she attended
regular school. Her voice was normal. The 12-year-old
sister (III:1) also showed mild retrognathia; thin ver-
million border of the upper lip; low-set, posteriorly an-
gulated ears with overfolded helices; high-arched palate
with a minimal nick in the uvula; and mild muscular
hypotonia (fig. 1g and h). Her OFC was 52.3 cm (25th
centile), and her height was 143.8 cm (10th centile). She
had a history of recurrent bronchitis, but immunologic
investigations revealed normal results. She attends a spe-
cial school because of minor learning difficulties. Her
voice is normal. Echocardiographic, immunologic, en-
docrine, and pharyngoscopic studies in the parents and
sibs of the patient did not show any abnormalities. There
were neither attention-deficit/hyperactivity disorders nor
behavioral or psychiatric problems in any family
members.
Karyotyping and FISH with the probes D22S75, Tu-
ple1, and cHKAD26, of chromosomes from T lympho-
cytes and fibroblasts of the patient, did not reveal any
chromosomal aberration or microdeletion in the com-
monly deleted 22q11.2 region. FISH with the probes
D22S75 and cHKAD26, in the patient’s mother and sibs,
also showed normal signals on both chromosomes
22. STRP analyses of seven loci within (D22S1638,
D22S941, D22S1648, D22S944, D22S1623, D22S264,
and D22S311) and two loci flanking (D22S427 and
D22S306) the 22q11.2 deletion region in the patient and
her parents demonstrated heterozygosity of five markers
in the patient. Four markers showed only one allele, but
the parental allele constellation was uninformative. At
two of the uninformative markers, the patient’s mother
was heterozygous. At one further distal marker,
D22S308, the patient had not inherited the maternal
allele. Subsequent STRP analyses with additional distal
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Figure 2 Results of STRP marker analyses in the core pedigree. Black bars denote a deletion; gray bars denote uninformative results
either within or flanking the deleted markers. Colors indicate the segregating haplotypes; note the identical paternal wild-type haplotype (dark
blue) in the mildly and severely affected sisters.
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Figure 3 FISH with BAC 438P22, confirming a deletion of D22S425, on the basis of a lack of the green fluorescein signal at one of the
chromosomes 22 (arrow) detected by red rhodamine signals from a centromeric 14/22 probe.
markers, in the patient and her family, demonstrated a
deletion of D22S308, D22S425, D22S303, and
D22S257 in the patient, her mother (II:1), and her older
sister (III:1), whereas markers D22S301, D22S156,
TOP1P2, D22S1144, and D22S1167 were informative
for heterozygosity (fig. 2).
Two BAC addresses—438P22 and 458J22—were
identified by library screen with D22S425 and were con-
firmed by PCR from single clones. FISH with BAC
438P22 showed only a signal on one chromosome 22
in 50 metaphases from the patient (fig. 3), her sister, and
her mother, whereas in her brother, father, and maternal
grandparents signals on both chromosomes 22 were
seen. In addition, FISH with the probes M-bcr/abl and
m-bcr/abl showed a deletion of the BCR (D22S257) sig-
nal on one of the chromosomes 22 in the patient. FISH
with BAC 458J22 (D22S425) in the patient showed sig-
nals on both chromosomes 22, but one signal appeared
weaker than the other, in most of the 30 analyzed met-
aphases. Fiber-FISH with both BACs in a control re-
vealed a relatively short signal by BAC 438P22, which
was located at one end of the very long but at least two-
times-interrupted signal by BAC 458J22 (fig. 4). Both
BACs were negative for markers D22S1709, D22S308,
D22S303, D22S257, D22S301, D22S156, TOP1P2,
D22S1144, and D22S1167. Therefore, BAC 458J22
does not span either of the deletion breakpoints. On
interphase nuclei from a control, BAC 458J22 appeared
only rarely as two signals; most of the time it gave split
signals. These findings could be explained if BAC 458J22
contained repetitive elements that led to a signal on both
chromosomes 22 despite deletion of D22S425.
We have demonstrated a novel microdeletion at
22q11.2 in a patient with DGS who had neither a de-
letion in the known 3-Mb 22q11.2 deletion region nor
any other detectable chromosomal aberration such as
deletion 10p. The deletion most probably comprises the
loci D22S306, D22S308, D22S425, D22S303, and
D22S257 in all affected family members. According to
the physical map provided by Morrow et al. (1995), the
size of the deletion should be ∼2 Mb; however, the exact
physical distance to the distal breakpoint is not known.
The presented deletion is distal not only to the com-
monly deleted 22q11.2 region but also to the small distal
deletions described by Kurahashi et al. (1996, 1997) and
O’Donnell et al. (1997) (fig. 5). Since this novel deletion
is adjacent to the commonly deleted region, a position
effect on genes located in the commonly deleted region,
or vice versa, may explain the DGS/VCFS phenotype in
both the patient and those with the common or pub-
lished small distal 22q11.2 deletions. Since four of the
markers (i.e., D22S306, D22S308, D22S425, and
D22S303) from our novel deletion region are within the
immunoglobulin light-chain (IGLC) region, immuno-
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Figure 4 Fiber-FISH with the D22S425-positive BAC clones 438P22 (red) and 458J22 (green), suggesting the existence of repetitive
elements within BAC 458J22.
Figure 5 Scheme of the known DGS/VCFS deletion region (Morrow et al. 1995; Carlson et al. 1997b) and the novel microdeletion in
the presented family. pSRO: proximal shortest region of deletion overlap defined by Carlson et al. (1997b); dSRO: distal shortest region of
deletion overlap defined by Kurahashi et al. ( 1996; 1997) and O’Donnell et al. (1997). Asterisk: ADU translocation breakpoint according to
Carlson et al. (1997b). del: deletion. Empty circles represent FISH probes. Shaded boxes below the scheme: location of low–copy-repeat elements
(Collins et al. 1997b).
deficiency in the affected family members may partly be
explained by a reduced number of possible combinations
during differentiation of antibody-forming cells. How-
ever, the cause of T-cell deficiency, which is the primary
immunologic finding in DGS, remains unclear. One
should also be aware that deletions of the IGLC region
in differentiated B-lymphocytes is not a pathological
finding and could lead to misdiagnosis of a germ-line
deletion.
Since it has been shown that 22q11 contains several
low-copy repeats (Collins et al. 1997a), one might also
consider that there are either similar genes or several
copies of critical genes within the common and the pre-
sented deletion regions. Therefore, the search for such
similar genes might give a clue to the answer to the
question of whether any of the many genes already
known in the commonly deleted region might have a
major impact on the pathogenesis in 22q11.2 micro-
deletion syndromes—and, if so, which ones.
Recently, Chen et al. (1997) identified flanking repeat
sequences within the Smith-Magenis syndrome critical
region, which may lead to this common microdeletion
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via chromosomal recombinations. Accordingly,Morrow
et al. (1997) mentioned a duplicated element within the
breakpoints of the common 3-Mb deletion inVCFS/DGS
patients. The proximal breakpoint of the 22q11.2 de-
letion in the family that we studied is in the same region
as the distal breakpoint of the known deletion (Carlson
et al. 1997b) and, therefore, may lie within this repeat
sequence. According to the corrected low–copy-repeat
map provided by Collins et al. (1997b), this repeat se-
quence also occurs between the genomic markers
D22S257 and D22S301, which flank the distal deletion
breakpoint in the atypical deletion presented here.
Therefore, it is conceivable that an intra- or interchro-
mosomal rearrangement because of repeated elements at
the deletion breakpoints has led to the presented deletion
as it is postulated in the common deletion. The repetitive
nature of the 22q11 region may also give rise to mis-
interpretation of results, as could have easily happened
with the FISH results of BAC 458J22, which appeared
to be not deleted but which, on the basis of Fiber-FISH,
seems to contain a multiple repeated element in addition
to the specific deleted sequence.
Affected family members with the presented micro-
deletion show several symptoms that are typical of the
common 22q11.2 microdeletion: interrupted aortic arch
type B; immunodeficiency; hypotonia; mild short stature;
microcephaly; short neck; learning difficulties; small,
squared-off ears with overfolded helices; retrognathia;
high-arched palate; choanal stenosis; and limb anomalies
(Ryan et al. 1997; Rauch et al. 1998b). However, the
typical facial gestalt, nearly always seen in the common
22q11.2 deletion, was not evident in this family. There-
fore, the characteristic facial gestalt of the common de-
letion should occur because of unique and probably con-
tiguous genes from that region. The search for this novel
22q11.2 microdeletion in patients with the 22q11.2 de-
letion phenotype but without the common deletion will
further delineate differences and similarities in both phe-
notype and genotype and could lead to a better under-
standing of mechanisms in the pathogenesis of DGS/
VCFS.
Because the patient’s mother and sister have only some
minor anomalies, the novel microdeletion shows a clin-
ical variability similar to that of the known 22q11.2
deletion. To explain the inter- and even intrafamilial var-
iability (De Silva et al. 1995; Leana-Cox et al. 1996;
Devriendt et al. 1997), additional factors have been
taken into consideration, such as imprinting, recessive
mutations or polymorphisms unmasked by hemizygos-
ity, unbalanced regulatory effects, a second-hit theory,
and environmental factors (Hall 1993; Dallapiccola et
al. 1996; Hatchwell 1996). However, the observation of
MZ twins with a concordant phenotype and 22q11.2
deletion strongly argues in favor of a predominant ge-
netic determination of the 22q11.2 deletion phenotype
(Rauch et al. 1998a). Since both affected sisters have
inherited the deletion from their mother, the considerable
clinical variation cannot be explained by imprinting.
Moreover, both sisters share the same paternal haplotype
at the remaining wild-type chromosome 22, which
makes the unmasking of different recessive mutations or
polymorphisms by hemizygosity unlikely. Therefore,
several types of 22q11.2 hemizygosity might result in a
susceptibility to certain syndromes, the expression of
which might be dependent on other factors, unlinked to
this region.
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RB1 Gene Mutations in Peripheral Blood DNA of
Patients with Isolated Unilateral Retinoblastoma
To the Editor:
Two recent reports in this Journal (Lohmann et al. 1997;
Sippel et al. 1998) indicated that the proportion of pa-
tients with isolated unilateral retinoblastoma who carry
RB1 gene mutations in constitutional cells is higher than
estimated previously (Vogel 1979; Draper et al. 1992).
Mutation analysis in patients with unilateral tumors is
important because it helps to significantly reduce the
number of infant relatives who require clinical surveil-
lance for retinoblastoma (Gallie 1997). Moreover, mo-
lecular investigation of these patients can identify car-
riers of mutations associated with incomplete penetrance
and reduced expressivity and thus can extend our knowl-
edge of the genotype-phenotype correlation (Gallie
1997; Lohmann et al. 1997). We have now analyzed
additional tumors and have found that the frequency of
constitutional mutations in patients with isolated uni-
lateral retinoblastoma is not as high as indicated by our
previous study (Lohmann et al. 1997).
Forty-two retinoblastomas that showed loss of con-
stitutional heterozygosity (LOH) at the intragenic loci
RBi2 (Toguchida et al. 1993) or RB1.20 (Yandell et al.
1989) were available for mutation analysis. Twenty-one
of these tumors had been part of a previous study but
were not analyzed for small mutations at that time (Loh-
mann et al. 1997). We analyzed the methylation status
at the 5′ end of the RB1 gene by Southern blot analysis,
using the methylation-sensitive enzymes BssHII and
SacII as described elsewhere (Greger et al. 1994). Hy-
permethylation was identified in tumors from six pa-
tients.We performed SSCP to screen for smallmutations,
using a method reported elsewhere (Lohmann et al.
1996). Single base substitutions, including 17 transitions
at CpG-dinucleotides, and small length alterations were
identified in 24 and 3 tumors, respectively. To identify
mutations in the remaining 10 tumors, we sequenced all
27 exons and the promoter region of the RB1 gene.
However, no small mutation was identified.
In all, mutations were identified in tumors from 32
(76%) of 42 patients (RB1 gene mutation database). In
the tumor of one patient (M6485), a missense base
change (c.929GrA, E310G) in exon 9 and a nonsense
mutation in exon 15 (c.1399CrT, R467X) were iden-
tified in addition to LOH. The missense base change was
also present in peripheral blood DNA of this patient.
Further investigation showed that this variant RB1 allele
was inherited from the father and is, at least, carried by
four adult relatives who are unaffected by retinoblas-
toma. The sequence variant, which, to our knowledge,
has not been reported before, is expected to alter an
amino acid located N-terminal of the pocket domains A
and B (Hu et al. 1990). Only a few reported missense
mutations with putative oncogenic effect are located out-
side the regions that code for these domains (RB1 gene
mutation database). Considering that the tumor of pa-
tient M6485 also shows a somatic nonsense mutation
and LOH, the missense base change is probably a neutral
polymorphism and has not contributed to tumorigenesis.
However, detailed analyses are required, to demonstrate
that this sequence variant does not change the functional
properties of the Rb protein (Bremner et al. 1997; Ot-
terson et al. 1997).
In our previous study, we detected small RB1 gene
mutations in leukocyte DNA from 6 (17%) of 36 pa-
tients with isolated unilateral tumors (Lohmann et al.
1997). In the present study, none of the bona fide on-
cogenic mutations identified in tumors was also detected
in corresponding peripheral blood DNA by direct se-
quencing of PCR products. Therefore, when the data
presented here are included, the proportion of patients
with mutations in leukocyte DNA drops to 6 (9%) of
68. Because of mutational mosaicism (Lohmann et al.
1997; Sippel et al. 1998), this figure underestimates the
true prevalence of constitutional RB1 gene mutations in
patients with isolated unilateral retinoblastoma. How-
ever, in almost all patients with isolated unilateral reti-
noblastoma who have affected children, the mutation is
readily detectable in peripheral blood DNA (Sippel et
al. 1998; authors’ unpublished data). It is reasonable to
